Carmel M. Lynch

Carmel has +25 years of experience in biotechnology, spanning from discovery research to clinical development, with an emphasis in translational medicine. +15 years specializing in ADCs; led Nonclinical and Clinical Pharmacology development of Adcetris(tm) ADC at SeaGen from pre-IND to approval in 2011.